DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Fananserin
Fananserin
Among a Series of Novel D4 Dopamine Receptor Agonists and Antagonists Jeremiah J
Pharmaceuticals Appendix
Ligand-Based Pharmacophore Studies in the Dopaminergic System Amar P
Atypical Antipsychotic Drugs in Schizophrenia
The Past and Future of Novel, Non-Dopamine-2 Receptor Therapeutics for Schizophrenia: a Critical and Comprehensive Review T
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
PHARMACEUTICAL APPENDIX to the HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2008) (Rev
5-HT2A Receptors in the Central Nervous System the Receptors
A Positron Emission Tomography Study Of
Antipsychotic Dosing: Extended, and Transient Philip Seeman 1, Gary Remington 1, 2, 3
Repeated Antipsychotic Treatment Progressively Potentiates Inhibition on Phencyclidine-Induced Hyperlocomotion, but Attenuates I
Stembook 2018.Pdf
WO 2015/195478 Al 23 December 2015 (23.12.2015) P O P C T
Integrating the Neurobiology of Schizophrenia
New Information of Dopaminergic Agents Based on Quantum Chemistry Calculations Guillermo Goode‑Romero1*, Ulrika Winnberg2, Laura Domínguez1, Ilich A
Sif 00 Prelim (Bc-D)
RGMA, RFA 06051S1 2/1996 Wipo. Stephen Jackson,S Harlow;S Januszp WO 96/24353 8/1996 WIPO
( 12 ) United States Patent
Top View
Combinations of 5-Ht2a Inverse Agonists And
Pharmaceuticals Appendix
(12) United States Patent (10) Patent No.: US 7,855,195 B2 Buntinx (45) Date of Patent: *Dec
Large-Scale Transcriptional Profiling of Molecular Perturbations Reveals
(12) Patent Application Publication (10) Pub. No.: US 2005/0176680 A1 Lalji Et Al
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Ep 1547650 A1
Perspectives
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Are Patients with Schizophrenia Spectrum Disorders More Prone To
Known Bioactive Library: Tocriscreen Mini Library 2
Customs Tariff - Schedule Xxi - 1
Combination of a Sedative and a Neurotransmitter Modulator, and Methods for Improving Sleep Quality and Treating Depression
Bioactive Compound Library Plus (96-Well)
2. Serotonin 5-HT1A Receptor Signalling: G-Protein Activation
5-HT Receptor Serotonin Receptor; 5-Hydroxytryptamine Receptor
Dopamine Receptors
The Pipeline and Future of Drug Development in Schizophrenia
The Role of Serotonin in Antipsychotic Drug Action Herbert Y
Harmonized Tariff Schedule of the United States (2006) (Rev
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
(12) United States Patent (10) Patent No.: US 9,592.288 B2 Schultz Et Al
(12) Patent Application Publication (10) Pub. No.: US 2005/0085463 A1 Weiner Et Al
Pharmaceutical Appendix to the Tariff Schedule 2
Mechanism of Action of Atypical Antipsychotic Drugs (PDF)
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
University of Birmingham Central 5-HT Receptors and Their
University of Birmingham Central 5-HT Receptors
Certificate of Analysis
Pharmaceutical Appendix to the Tariff Schedule 2
A Positron Emission Tomography Study of Quetiapine in Schizophrenia: a Preliminary Finding of an Antipsychotic Effect with Only
Wo 2007/005962 A2
Antipsychotics for the Treatment of Sympathomimetic Toxicity: a Systematic Review Q ⇑ Nicholas J
A Critical Review of the Pharmacology and Clinical Effects of Current and Future Therapeutic Agents
A DFT Investigation of the Relationships Between Electronic Structure And
Dopamine Receptor
Receptor Tyrosine Kinase Targeting in Glioblastoma: Performance, Limitations and Future Approaches 57
Rev Iss Web Cns 12513 22-5 404..412
Ylated (52) U.S